Jeroen van den Berg
@jervdberg.bsky.social
570 followers
300 following
21 posts
post-doc with Alexander van Oudenaarden @hubrecht | PhD with René Medema @NKI | Canman lab @ Columbia NYC | single cell sequencing | scEdU-seq| DNA replication | CRISPR | Genomic instability & Cell Fate | he/him
Posts
Media
Videos
Starter Packs
Reposted by Jeroen van den Berg
Reposted by Jeroen van den Berg
Reposted by Jeroen van den Berg
Reposted by Jeroen van den Berg
Reposted by Jeroen van den Berg
Reposted by Jeroen van den Berg
Reposted by Jeroen van den Berg
Reposted by Jeroen van den Berg
Reposted by Jeroen van den Berg
AmélieFT@AFTLab
@amelieft.bsky.social
· Aug 13
Ubiquitination of the histone variant mH2A1.2 prevents toxic RAD18 accumulation at a subset of genomic loci upon replication stress
Using biochemical assays and a mutant disrupting RNF168-dependent ubiquitination of
the histone variant macroH2A1.2, Galloy et al. identified an unexpected role for histone
mH2A1.2 ubiquitination in p...
www.cell.com
Reposted by Jeroen van den Berg
Abdel Mazouzi
@amazouzi.bsky.social
· Aug 13
Reposted by Jeroen van den Berg
Sarah Moser
@sarahmoser.bsky.social
· Aug 13
NASP modulates histone turnover to drive PARP inhibitor resistance - Nature
PARP inhibitor treatment triggers histone release from the chromatin in cancer cells; consequently, targeting the histone chaperone NASP renders cells vulnerable to PARP inhibition.
www.nature.com
Reposted by Jeroen van den Berg
Reposted by Jeroen van den Berg
Reposted by Jeroen van den Berg